Vasculitis in 2011: the renaissance of granulomatous inflammation in AAV.
In 2011, the year that subtypes of ANCA-associated vasculitis (AAV) were officially renamed according to key pathological characteristics, important progress was made not only in differentiating these subtypes, but also in understanding—and treating—their eponymous manifestations.
Department of Rheumatology, University Hospital of Southampton NHS Foundation Trust, University of Southampton, Southampton SO16 6YD, UK.
Stephan D
SD
Gadola
Wolfgang L
WL
Gross
D019268:Antibodies, Antineutrophil Cytoplasmic / Q000097:blood*; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D014890:Granulomatosis with Polyangiitis / Q000097:blood / Q000145:classification / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D016571:Neural Networks, Computer; D000069283:Rituximab; D009626:Terminology as Topic; D014657:Vasculitis / Q000097:blood / Q000145:classification / Q000175:diagnosis* / Q000188:drug therapy
D019268:Antibodies, Antineutrophil Cytoplasmic; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab